Safety and Efficacy Study Using Rexin-G for Breast Cancer
Clinical trial NCT00505271 · COMPLETED
Trial details
- NCT number
- NCT00505271
- Sponsor
- Epeius Biotechnologies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.